Table 4.
Comparison of Primary Endpoints and Healthcare Utilization Between Groups in the Practical, Randomized, Controlled Triala
| Measure | MCCO-Original | MCCO-Enhanced | P-Value |
|---|---|---|---|
| SIP13 | 21.7 (2.0) (n = 76) |
22.4 (1.8) (n = 75) |
0.77 |
| MSFC14 | −0.80 (0.24) (n = 81) |
−0.63 (0.22) (n = 84) |
0.51 |
| MSSE15 | 64.5 (2.8) (n = 77) |
62.5 (2.6) (n = 77) |
0.50 |
| SGSM-GSC16 | 23.3 (0.72) (n = 77) |
23.2 (0.67) (n = 77) |
0.96 |
| SGSM-PC16 | 33.2 (0.47) (n = 77) |
33.7 (0.43) (n = 77) |
0.30 |
| EQ-5D index score17 | 0.757 (0.025) (n = 75) |
0.756 (0.023) (n = 75) |
0.96 |
| EQ-5D Visual Analog Scale17 | 76.3 (2.6) (n = 75) |
70.2 (2.4) (n = 74) |
0.04 |
| Ever hospitalized | 1.24% (2.04%) (n = 80) |
2.86% (1.87%) (n = 83) |
0.46 |
| Ever admitted to ED | 3.4% (4.1%) (n = 80) |
12.4% (3.8%) (n = 83) |
0.08 |
| Ever missed paid employment in previous 3 months (only those employed) | 3.7% (7.1%) (n = 55) |
14.1% (6.8%) (n = 48) |
0.17 |
| Days paid for someone to help with daily activities | 0.25 (0.058) (n = 80) |
0.15 (0.052) (n = 83) |
0.10 |
| Number of medical office visits | 7.36 (1.59) (n = 70) |
8.53 (1.31) (n = 77) |
0.46 |
| Number of home health visits | 1.58 (0.42) (n = 70) |
0.79 (0.34) (n = 77) |
0.058 |
| Number of prescriptions | 11.0 (1.10) (n = 80) |
10.5 (1.00) (n = 82) |
0.68 |
a
Results are adjusted for age, gender, marital status, race, years of education, work status, and MicroCog general proficiency. All data shown are least square means and standard error.